Fyn kinase inhibition as a novel therapy for Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, February 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#39 of 1,465)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 32 news stories from 22 outlets.

Même si les chercheurs étudient la protéine tau depuis des décennies, les mécanismes moléculaires par lesquels la protéine tau…

AB SCIENCE COMMUNICATES RESULTS FROM PHASE 2B/3 STUDY EVALUATING MASITINIB IN ALZHEIMER’S DISEASE Paris, December 18, 2020, 8.30a…

AB SCIENCE COMMUNICATES RESULTS FROM PHASE 2B/3 STUDY EVALUATING MASITINIB IN ALZHEIMER’S DISEASE Paris, December 18, 2020, 8.30a…

AB SCIENCE COMMUNICATES RESULTS FROM PHASE 2B/3 STUDY EVALUATING MASITINIB IN ALZHEIMER’S DISEASE Paris, December 18, 2020, 8.30a…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 28 additional news stories.